(Q43420011)

23 November 2017

title

Erythromycin, an inhibitor of mitoribosomal protein biosynthesis, alters the amphotericin B susceptibility of Candida albicans (English)

1 reference

23 November 2017

1 reference

1 reference

1 reference

Kevin Kavanagh

2

1 reference

ORCID Public Data File 2021

author name string

Patrick Geraghty

series ordinal

1

1 reference

23 November 2017

publication date

1 February 2003

1 reference

Journal of Pharmacy and Pharmacology

23 November 2017

published in

1 reference

23 November 2017

volume

55

1 reference

23 November 2017

issue

2

1 reference

23 November 2017

page(s)

179-184

1 reference

Structural basis for selectivity and toxicity of ribosomal antibiotics

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1211%2F002235702469

Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702469

Candida dubliniensis: phylogeny and putative virulence factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702469

Erythromycin slows aging of Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702469

Nosocomial fungal infections: candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702469

Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702469

Epidemiological shifts in opportunistic and nosocomial Candida infections: mycological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702469

Physiological implications of sterol biosynthesis in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702469

National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702469

The past, present and future of antimycotic combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702469

Effects of erythromycin, clarithromycin, roxithromycin and azithromycin on murine gut colonization by Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702469

Biochemistry, cell biology and molecular biology of lipids of Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702469

Protein synthesis on ribosomes isolated from rat liver mitochondria: sensitivity to erythromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702469

Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta5,6-desaturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702469

21 January 2018

Identifiers

DOI

10.1211/002235702469

1 reference

23 November 2017

1 reference